Ultomiris Approved in Europe for Adults With AChR-positive gMG
The European Commission has approved Ultomiris (ravulizumab) as an add-on to standard therapy for adults with generalized myasthenia…
Articles by Lindsey Shapiro, PhD
Despite Side Effects, Pyridostigmine Perceived as Moderately Effective
Pyridostigmine is perceived as being moderately effective at easing myasthenia gravis (MG) symptoms, but often is accompanied by side…
Spherix Analyzes Reviews of gMG Therapies, Vyvgart, Ultomiris
Neurologists find both Vyvgart (efgartigimod) and Ultomiris (ravulizumab-cwvz) effective for treating generalized myasthenia gravis (gMG), but believe…
Risk Factors Seen When Ocular MG Switches to gMG After Thymectomy
Risk factors for converting ocular myasthenia gravis (MG) to generalized myasthenia gravis (gMG) after a thymectomy, or thymus…
TRAF6, Tied to Inflammation in MG, at High Levels in Immune B-Cells
Levels of the tumor necrosis factor receptor-associated factor 6 (TRAF6) protein in immune B-cells are higher than normal in people…
Newly Found Cellular Changes May Underlie MG in Thymoma Patients
Researchers have found that a set of cells called medullary thymic epithelial cells, or mTECs, may play a role in…
Report Examines Anesthetic Management of Subclinical MG
Careful administration and monitoring of anesthetic medications may prevent complications in people with subclinical myasthenia gravis (MG) undergoing surgery,…
Ocular MG Signs Emerge After COVID-19 Vaccine But Cause Unclear
A man developed signs of myasthenia gravis (MG) with eye symptoms about a month after receiving the first shot…
European Committee Recommends Efgartigimod Approval for gMG
European regulators have recommended efgartigimod be approved as an add-on therapy for adults with generalized myasthenia gravis (gMG)…
Vyvgart Opening to gMG Patients in UK Under Early Access Program
Vyvgart (efgartigimod alfa-fcab) is being made available to eligible adults with generalized myasthenia gravis (gMG) in the U.K.